<DOC>
	<DOCNO>NCT00417833</DOCNO>
	<brief_summary>Purpose : Determine short-term safety intravitreal bevacizumab multifocal electroretinography ( mf-ERG ) . Methods : 120 eye choroidal neovascularization , proliferative diabetic retinopathy retinal vein occlusion receive intravitreal bevacizumab ( 2.5mg/0.1cc ) . All patient underwent best correct visual acuity , fluorescein angiography , optical coherent tomography mf-ERG 1 month treatment .</brief_summary>
	<brief_title>Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab ( Avastin ) Treatment</brief_title>
	<detailed_description />
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Proliferative diabetic retinopathy , vascular vein oclussion , choroidal neovascularization Multifocal electroretinogram intravitreal bevacizumab 1,3 , 6 month treatment Completely study Complications Tractional Detachment Endophthalmitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>